HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Frederik Geisler Selected Research

4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)

1/2018Ultraearly Intravenous Thrombolysis for Acute Ischemic Stroke in Mobile Stroke Unit and Hospital Settings.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Frederik Geisler Research Topics

Disease

7Stroke (Strokes)
01/2023 - 06/2013
3Ischemic Stroke
01/2023 - 09/2016
1Cardiovascular Diseases (Cardiovascular Disease)
10/2022
1Hypersensitivity (Allergy)
10/2022
1Brain Ischemia (Cerebral Ischemia)
01/2021

Drug/Important Bio-Agent (IBA)

2Biomarkers (Surrogate Marker)IBA
01/2023 - 01/2023
1TabletsIBA
10/2022
14- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA
01/2018
1Tissue Plasminogen Activator (Alteplase)FDA Link
09/2016

Therapy/Procedure

2Contraindications
01/2023 - 10/2022
2Therapeutics
01/2023 - 01/2023
2Thrombectomy
01/2023 - 01/2021
1Time-to-Treatment
01/2021
1Activities of Daily Living (ADL)
01/2018
1Thrombolytic Therapy
06/2013